Skip to main content
. 2016 Jun 8;6:26994. doi: 10.1038/srep26994

Table 1. Demographic data and clinical manifestation of patients with compound heterozygosity for Hb Adana and deletional (-α3.7) or nondeletional α-thalassaemia.

  Sex-Age (years) Ethnic Group Clinical Manifestation
P1 F-42 Malay Presented at 30-year-old with hypochromic and microcytic anaemia. No transfusion was required except during pregnancy. Started on 3–4 monthly transfusions at 41-year-old for symptomatic anaemia.
P2 F-5 Malay Presented at 2 years suggestive of α-thalassaemia and unusual haemoglobinopathy. Presented again at 5 years with chronic anaemia and significant hepatosplenomegaly. Patient on hyper-transfusion regimen.
P3 F-0.5 Malay Presented at 5 months with background history of conjugated bilirubin, raised liver enzyme and neonatal hepatitis. Peripheral blood film suggestive of haemolysis and enzymopathy.
P4 F-25 Malay Transfused since 6-year-old.
P5 M-15 Malay Case notes were not available.
P6 M-13 Malay Transfused since 5-month-old.
P7* F-11 Malay Patient showed haemolytic anaemia with frontal bossing, tinge of jaundice, maxillary hyperplasia and hepatosplenomegaly.
P8* F-9 Malay Presented at 1 year 7 months and diagnosed with HbH disease with HbCS. Presented again at 9 years with anaemia and hepatosplenomegaly.
P9* F-12 Malay Case notes were not available.
P10* M-15 Malay Presented at 3 years old with Hb between 6 to 7.8 g/dL. Noted fall off in height centiles at 14 years old with no puberty features and increasing spleen size (9 cm). Started on regular transfusion at 8 weekly intervals.
P11 M-9 Malay-Indian Presented with anaemia (Hb 5.5 g/dL) at 6.5 years and given first transfusion, followed by 2 more in the same year. Patient remains asymptomatic and is able to maintain Hb between 7.4–9.5 g/dL without transfusion.
P12 M-13 Chinese Presented with anaemia (Hb 5.8 g/dL) and hepatosplenomegaly at 2-month-old. First transfused at 4-month-old and transfused again at 7-month-old. Maintained on regular transfusion since 8-year-old to ensure normal growth and facies.
P13 M-9 Malay Presented at 1-year-old with pallor and hepatosplenomegaly. Patient on hyper-transfusion regimen (4–6 weeks) due to poor growth.

P1: α-thalassaemia intermedia (αcodon 59α/-α3.7).

P2–P12: Severe α-thalassaemia intermedia (αcodon 59α/αCSα).

P13: Severe α-thalassaemia intermedia (αcodon 59α/αPakséα).

P7–P10*: Patients with one sibling confirmed with severe α-thalassaemia intermedia (αcodon 59α/αCSα).